Alterations should be built cautiously and the frequency of blood glucose checking should be elevated. Changes in concomitant oral antidiabetic treatment may be needed. BRIEF Protection Assertion: Failure to utilize the Dexcom Continuous Glucose Monitoring Program and its components in accordance with the Guidelines for use delivered using your https://leanaa799iuc2.slypage.com/profile